Clinical Trial Update: Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing secukinumab to ustekinumab in subjects with plaque psoriasis has completed and posted results in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Secukinumab (secukinumab)
• USTEKINUMAB (USTEKINUMAB)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Plaque Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2019-07-09